Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 8Unknown 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 25Leukemia, Myeloid, Acute 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Lymphoma 21Burkitt Lymphoma 19Myelodysplastic Syndromes 18Leukemia 17Lymphoma, Non-Hodgkin 15Lymphoma, Follicular 15Lymphoma, Large B-Cell, Diffuse 14Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Mantle-Cell 12Lymphoma, B-Cell, Marginal Zone 12Neoplasms, Plasma Cell 11Lymphoma, Large-Cell, Immunoblastic 11Hodgkin Disease 11Breast Neoplasms 11Recurrence 10Congenital Abnormalities 9Sarcoma 8Myeloproliferative Disorders 8Dendritic Cell Sarcoma, Interdigitating 8Leukemia, Myelomonocytic, Juvenile 7Leukemia, Myeloid, Chronic-Phase 7Lymphoma, T-Cell, Cutaneous 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Hairy Cell 6Central Nervous System Neoplasms 6Sezary Syndrome 5

Interventions

Trastuzumab 3Taxes 3Radiotherapy 3Paclitaxel 3Cyclophosphamide 3Epirubicin 2Doxorubicin 2Docetaxel 2Biopsy 2trastuzumab biosimilar HLX02 1talimogene laherparepvec 1romidepsin 1pertuzumab 1pembrolizumab 1pegfilgrastim 1nintedanib 1neratinib 1grapiprant 1eribulin 1caficrestat 1bemcentinib 1Tamoxifen 1Razoxane 1Radiation 1PF-05280014 1Ontruzant 1Ogivri 1Nivolumab 1Neoadjuvant Therapy 1Lapatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Inflammatory Breast Neoplasms × Filgrastim × Clear all
NCT00346229 2016-03-22

Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

Duke University

Phase 1 Terminated
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡